Initial versus delayed accelerated hyperfractionated radiation therapy and concurrent chemotherapy in limited small-cell lung cancer: A randomized study

Journal of Clinical Oncology

Volumn 15, Issue 3, 1997, Pages 893-900

  Jeremic, B ^a   Shibamoto, Y ^a   Acimovic, L ^a   Milisavljevic, S ^a  

^a University Hospital   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; ETOPOSIDE;

ADULT; AGED; ALOPECIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; IMMUNE DEFICIENCY; INFECTION; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; LUNG SMALL CELL CANCER; LUNG TOXICITY; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 0031052352     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1997.15.3.893     Document Type: Article

References (42)

1. Byhardt RW, Libnoch JA, Cox JD, et al: Local control of intrathoracic disease with chemotherapy and role of prophylactic cranial irradiation in small cell carcinoma of the lung. Cancer 47:2239-2246, 1981
2. Bunn PA, Lichter AS, Makuch RW, et al: Chemotherapy alone or chemotherapy with chest radiotherapy in limited stage small cell lung cancer. Ann Intern Med 106:655-662, 1987
3. Perez CA, Einhorn L, Oldham RK, et al: Randomized trial of radiotherapy to the thorax in limited small cell carcinoma of the lung treated with multiagent chemotherapy and elective brain irradiation: A preliminary report. J Clin Oncol 2:1200-1208, 1984
4. Warde P, Payne D: Does thoracic irradiation improve survival and local control in limited stage small cell carcinoma of the lung? A meta-analysis. J Clin Oncol 6:890-895, 1992
5. Pignon JP, Arriagada R, Ihde DC, et al: A meta-analysis of thoracic radiotherapy for small cell lung cancer. N Engl J Med 327:1618-1624, 1992
6. Johnson DH, Turrisi AT, Chang AY, et al: Alternating chemotherapy and twice-daily thoracic radiotherapy in limited-stage small-cell lung cancer: A pilot study of the Eastern Cooperative Oncology Group. J Clin Oncol 11:879-884, 1993
7. Arriagada R, Le Chevalier T, Ruffié P, et al: Alternating radiotherapy and chemotherapy in limited small cell lung cancer: The IGR protocols. Lung Cancer 10:S289-S298, 1994 (suppl 1)
8. Johnson BE: Concurrent approaches to combined chemotherapy and chest radiotherapy for the treatment of patients with limited stage small cell lung cancer. Lung Cancer 10:S281-S287, 1994 (suppl 1)
9. Perry MC, Eaton WL, Propert KJ, et al: Chemotherapy with or without radiation therapy in limited small cell carcinoma of the lung. N Engl J Med 316:912-918, 1987
10. Schultz HP, Nielsen OS, Sell A, et al: Timing of chest irradiation with respect to combination chemotherapy in small cell lung cancer, limited disease. Lung Cancer 4:153, 1988
11. Murray N, Coy P, Pater JL, et al: Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. J Clin Oncol 11:336-344, 1993
12. Carney DN, Mitchell JB, Kinsella TJ: In vitro radiation and chemotherapy sensitivity of established cell lines of human small cell lung cancer and its cell morphological variants. Cancer Res 43:2806-2811, 1983
13. Muggia FM, Krezoski SK, Hansen HH: Cell kinetic studies in patients with small cell carcinoma of the lung. Cancer 34:1683-1690, 1974
14. Shibamoto Y, Shibata T, Miyatake S, et al: Assessment of the proliferative activity and radiosensitivity of human tumours using the cytokinesis-block micronucleus assay. Br J Cancer 70:67-71, 1994
15. Jeremic B, Grujicic D, Jevremovic S, et al: Carboplatin and etoposide chemotherapy regimen for recurrent malignant glioma: A phase II study. J Clin Oncol 10:1074-1077, 1992
16. Jeremic B, Acimovic L, Mijatovic L: Carboplatin and etoposide in patients with advanced colorectal carcinoma. A phase II study. Cancer 71:2706-2708, 1993
17. Jeremic B, Shibamoto Y, Acimovic L, et al: Randomized trial of hyperfractionated radiation therapy with or without concurrent chemotherapy for stage III non-small-cell lung cancer. J Clin Oncol 13:452-458, 1995
18. Jeremic B, Shibamoto Y, Acimovic L, et al: Hyperfractionated radiation therapy with or without concurrent low-dose daily carboplatin/etoposide for stage III non-small cell lung cancer: A randomized study. J Clin Oncol 14:1065-1070, 1996
19. Begg AC, van der Kolk PJ, Emondt J, et al: Radiosensitization in vitro by cis-diammine (1,1 -cyclobutanedicarboxylato) platinum (II) (carboplatin, JM 8) and ethylenediammine-malonatoplatinum (II) (JM 40). Radiother Oncol 9:157-165, 1987
20. Minchan KJ, Bonner JA: The interaction of etoposide with radiation: Variation in cytotoxicity with the sequence of treatment. Life Sci 53:237-242, 1993
21. Skarlos DV, Samantas E, Kosmidis P, et al: Randomized comparison of etoposide-cisplatin vs etoposide-carboplatin and irradiation in small-cell lung cancer. A Hellenic Co-operative Oncology Group study. Ann Oncol 5:601-607, 1994
22. Freedman LS: Tables of the numbers of patients required in clinical trials using the logrank test. Stat Med 1:121-129, 1982
23. Choi NC, Carey RW: Importance of radiation dose in achieving improved locoregional tumor control in limited small-cell lung carcinoma: An update. Int J Radiat Oncol Biol Phys 17:307-310, 1989
24. Cox JD, Azarnia N, Byhardt RW, et al: A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: Possible survival benefit with ≥ 69.6 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-small cell lung carcinoma: Report of Radiation Therapy Oncology Group 83-11. J Clin Oncol 8:1543-1555, 1990
25. Coy P, Hodson DI, Murray N, et al: Patterns of failure following loco-regional radiotherapy in the treatment of limited stage small cell lung cancer. Int J Radiat Oncol Biol Phys 28:355-362, 1994
26. Murray N, Coldman A: The relationship between thoracic irradiation timing and long-term survival in combined modality therapy of limited stage small cell lung cancer (LSCLC). Proc Am Soc Clin Oncol 14:360, 1995 (abstr)
27. Komaki R, Shin DM, Glisson BS, et al: Interdigitating versus concurrent chemotherapy and radiotherapy for limited small cell lung cancer. Int J Radiat Oncol Biol Phys 31:807-811, 1995
28. Bonnefoi H, Zulian GB, Mirimanoff RO, et al: Priming low-dose chest radiotherapy followed by chemotherapy for limited small-cell lung cancer. Ann Oncol 5:771-774, 1994
29. Ngan S, Ball D, Bull C, et al: Limited small cell lung cancer: The effect of radiotherapy on local control following response to chemotherapy. Int J Radiat Oncol Biol Phys 21:459-462, 1991
30. Ochs JJ, Tester WJ, Cohen MH: Salvage radiation therapy for intrathoracic small cell carcinoma of the lung progressing on combination chemotherapy. Cancer Treat Rep 67:1123-1126, 1983
31. Goldie JG, Coldman AJ: A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate. Cancer Treat Rep 63:1727-1733, 1979
32. Johnson BE, Salem C, Nesbitt J, et al: Limited stage small cell lung cancer treated with concurrent hyperfractionated chest radiotherapy and etoposide/cisplatin. Lung Cancer 9:S21-S26, 1993 (suppl 1)
33. Turrisi AT: Considerations on radiotherapy dose intensity for limited small cell lung cancer. Lung Cancer 10:S167-S173, 1994 (suppl 1)
34. Johnson DH, Kim K, Turris AT, et al: Cisplatin (P) & etoposide (E) + concurrent thoracic radiotherapy (TRT) administered once versus twice daily for limited-stage (LS) small-cell lung cancer (SCLC): Preliminary results of an intergroup trial. Proc Am Soc Clin Oncol 13:333, 1994 (abstr)
35. Coy P, Hodson I, Payne DG, et al: The effect of dose of thoracic irradiation on recurrence in patients with limited stage small cell lung cancer. Initial results of a Canadian multicenter randomized trial Int J Radiat Oncol Biol Phys 14:219-226, 1988
36. Choi NC, Hemdon J, Rosenman J, et al: Phase I study to determine the maximum tolerated dose (MTD) of radiation in standard daily (QD) and accelerated twice daily (BID) radiation schedules with concurrent chemotherapy (CT) for limited stage smal cell lung cancer. CALGB 8837. Proc Am Soc Clin Oncol 14:363, 1995 (abstr)
37. Shaw EG, Su JQ, Eagan RT, et al: Prophylactic cranial irradiation'in complete responders with small-cell lung cancer: Analysis of the Mayo Clinic and North Central Cancer Treatment Group data bases. J Clin Oncol 12:2327-2332, 1994
38. Rubenstein JH, Dosoretz DE, Katin MJ, et al: Low doses of prophylactic cranial irradiation effective in limited stage small cell carcinoma of the lung. Int J Radiat Oncol Biol Phys 33:329-337, 1995
39. Ohnoshi T, Ueoka H, Kawahara S, et al: Comparative study of prophylactic cranial irradiation in patients with small cell lung cancer achieving a complete response: A long-term follow-up result. Lung Cancer 10:47-54, 1993
40. Johnson BE, Ihde DC, Bunn PA, et al: Patients with small-cell lung cancer treated with combination chemotherapy with or without irradiation. Data on potential cures, chronic toxicities, and late relapses after a five- to eleven-year follow-up. Ann Intern Med 103:430-438, 1985
41. Turrisi A, Rector D, Janaki LM, et al: Long term follow-up (F/U) from SWOG 8269 concurrent cisplatin (P), etoposide (E), vincristine (V) and daily thoracic radiotherapy (TRT) for the treatment of limited small-cell lung cancer (LSCLC): Patterns of failure and second tumors. Lung Cancer 11:172, 1994 (suppl 1)
42. Giaccone G, Dalesio O, McVie GJ, et al: Maintenance chemotherapy in small-cell lung cancer: Long-term results of a randomized trial. J Clin Oncol 11:1230-1240, 1993